Mekhael Mira, Kristensen Helle Ø, Larsen Helene Mathilde, Juul Therese, Emmanuel Anton, Krogh Klaus, Christensen Peter
Department of Surgery, Aarhus University Hospital, DK8200 Aarhus, Denmark.
Danish Cancer Society Centre for Research on Survivorship and Late Adverse Effects after Cancer in the Pelvic Organs, DK8200 Aarhus, Denmark.
J Clin Med. 2021 Feb 13;10(4):753. doi: 10.3390/jcm10040753.
Transanal irrigation (TAI) has received increasing attention as a treatment option in patients with bowel dysfunction. This systematic review was conducted according to the PRISMA guidelines and evaluates the effect of TAI in neurogenic bowel dysfunction (NBD), low anterior resection syndrome (LARS), faecal incontinence (FI) and chronic constipation (CC). The primary outcome was the effect of TAI on bowel function. Secondary outcomes included details on TAI, quality of life (QoL), the discontinuation rate, adverse events, predictive factors for a successful outcome, and health economics. A systematic search for articles reporting original data on the effect of TAI on bowel function was performed, and 27 eligible studies including 1435 individuals were included. Three randomised controlled trials, one non-randomised trial, and 23 observational studies were included; 70% of the studies were assessed to be of excellent or good methodological quality. Results showed an improvement in bowel function among patients with NBD, LARS, FI, and CC with some studies showing improvement in QoL. However, discontinuation rates were high. Side effects were common, but equally prevalent among comparative treatments. No consistent predictive factors for a successful outcome were identified. Results from this review show that TAI improves bowel function and potentially QoL; however, evidence remains limited.
经肛门冲洗(TAI)作为肠功能障碍患者的一种治疗选择,越来越受到关注。本系统评价根据PRISMA指南进行,评估TAI在神经源性肠功能障碍(NBD)、低位前切除综合征(LARS)、大便失禁(FI)和慢性便秘(CC)中的效果。主要结局是TAI对肠道功能的影响。次要结局包括TAI的详细信息、生活质量(QoL)、停药率、不良事件、成功结局的预测因素以及卫生经济学。对报告TAI对肠道功能影响的原始数据的文章进行了系统检索,纳入了27项符合条件的研究,共1435例个体。其中包括三项随机对照试验、一项非随机试验和23项观察性研究;70%的研究被评估为方法学质量优秀或良好。结果显示,NBD、LARS、FI和CC患者的肠道功能有所改善,一些研究表明生活质量也有所提高。然而,停药率很高。副作用很常见,但在对照治疗中同样普遍。未发现一致的成功结局预测因素。本综述结果表明,TAI可改善肠道功能并可能改善生活质量;然而,证据仍然有限。